FDA Investigator Haitao Li
Haitao Li has inspections in 3 countries as of 17 Feb 2023. Haitao Li has collaborated with a combined 1358 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
6
Last Inspection Date:
17 Feb 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
India,
United States of America,
Singapore
Co-Investigator(s):
Alberto A Viciedo,
Ann Marie Montemurro,
Ariel Cruz Figueroa,
Azza Talaat,
Barbara J Maulfair,
Bernice F Hirsch,
Charles J Chacko,
Cynthia Jim, CSO,
Daniel J Grabicki,
Dennis Cantellops Paite,
Dinesh Kumar,
Douglas C Kovacs,
Edwin Melendez,
Emest F Bizjak,
Emmanuel J Ramos,
Erika V Butler,
Erin D Mccaffery,
Frank Wackes,
Gianine E Tompkins,
Guerlain Ulysse,
Helen Verdel,
Jason K Morgan,
Jawaid Hamid,
Jessica L Pressley,
Jogy George,
Jose E Melendez, DDC,
Jose M Cayuela,
Joy Rkozlowski Klena,
Julianne C Mccullough,
Justine Tomasso,
Karen E D'orazio,
Kelli F Dobilas,
Krishnaiah Yellela,
Kristy A Zielny,
Larry K Austin,
Lata C Mathew, PhD,
Li Li,
Liatte Kreuger, PharmD,
Linda Thai,
Maotang Xhou,
Maotang Zhou, PhD,
Maria Manzoni, PhD,
Matthew A Spataro,
Melissa T Roy,
Michael A Charles,
Michael R Goga,
Michael R Klapal,
Muralidhara B Gavini, PhD,
Nancy F Scheraga,
Nebil A Oumer,
Nicholas A Violand,
Nicole E Knowlton,
Niketa Patel,
Pankaj H Amin,
Paul L Bellamy,
Regina T Brown,
Richard W Thornton,
Richard W Thorntton,
Robin P Mathew,
Samina S Khan,
Seneca D Toms,
Shahla Parvizi,
Shirshendu K Deb, PhD,
Sidney B Priesmeyer,
Sinai Davis,
Stephen D Brown,
Stephen J Mottola,
Tamil Arasu, PhD,
Ted L Anderson,
Timothy T Kapsala,
Unnee Ranjan,
Walden H Lee,
Wayne D Mcgrath,
William J Leonard,
Yvins Dezan,
Zakaria I Ganiyu,
Zhaoyang Meng,
Zhijin Chen
Haitao Li's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2019 | EIR | American Regent, Inc. - EIR, 2019-01-25 |
May, 2016 | FDA 483 | Halo Pharmaceutical Inc - Form 483, 2016-05-27 |
July, 2017 | FDA 483 | LTS Lohmann Therapy Systems Corp. - Form 483, 2017-07-13 |
October, 2018 | FDA 483 | Alembic Pharmaceuticals Limited - Form 483, 2018-10-26 |
January, 2019 | FDA 483 | American Regent, Inc. - Form 483, 2019-01-25 |
May, 2024 | FDA 483 | Cipla Ltd. - Form 483, 2024-05-08 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more